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Edited by Ned ManteiAbstract The poor prognosis of glioblastoma patients is related
to diﬀuse brain invasion and interaction of tumor cells with
extracellular matrices (ECM). We describe expression and func-
tion of the FACIT-collagen XVI in glioblastomas. We found
upregulation of collagen XVI mRNA as well as protein in glio-
blastomas as compared to normal cortex. SiRNA knockdown re-
sulted in decreased cell adhesion whereas increased adhesion was
observed on surfaces coated with collagen XVI. The migration of
glioblastoma cells on this substrate remained unchanged. Our re-
sults demonstrate de-novo expression of collagen XVI in glio-
blastomas as part of the tumor speciﬁc remodeling of the ECM.
Structured summary:
MINT-6743179:
Collagen IV (uniprotkb:P02462-1) and Collagen XVI (uni-
protkb:Q07092) colocalize (MI:0403) by ﬂuorescence micros-
copy (MI:0416)
MINT-6743170:
GFAP (uniprotkb:P14136) and Collagen XVI (uni-
protkb:Q07092) colocalize (MI:0403) by ﬂuorescence micros-
copy (MI:0416)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The ﬁbril forming collagens I, III, V and VI are normally not
found in the brain parenchyma, but are components of mesen-
chymal structures like cerebral vessels and choroid plexus stro-
ma. Correspondingly, in gliomas only a minority of tumor cells
deposit these interstitial collagens in the peritumoral ECM.
Collagen IV is a major component of basement membranes be-
neath vascular endothelial cells and choroid plexus epithelial
cells in normal brain. In glioblastomas collagen IV is present
in virtually all tumor vessels, as well as in some giant glioma
cells and in tumor cells around vascular proliferations. In addi-
tion, rare types of gliomas, such as pleomorphic xanthoastro-
cytoma exhibit a collagen network around individual tumor
cells. Collagens VII and VIII are absent from normal brain,*Corresponding author. Fax: +49 251 8356971.
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doi:10.1016/j.febslet.2008.09.017but may be expressed in glioma tissues. The expression pattern
of collagens changes during growth of gliomas in cell culture.
Glioma cell lines deposit large amounts of collagens I, III, IV
and VI, a feature that is known as mesenchymal drift [1].
Remodeling of the tumor associated ECM is one mechanism
by which glioma cells force their invasion into brain tissue [2].
Using diﬀerential gene expression microarray analysis to com-
pare various glioma cells with increased versus decreased
migratory phenotype, we detected upregulation of collagen
XVI gene expression in the subpopulation of cells showing in-
creased migration [3]. Collagen XVI is a member of the ﬁbril
associated collagens with interrupted triple helices (FACIT-
collagens). The 213 kDa collagen XVI protein consists of 10
collagenous (Col) domains separated by 11 non-collagenous
(NC) regions. It is encoded by a single gene located on chro-
mosome 1p34-35 in humans and there is no evidence for diﬀer-
ent isoforms [4]. Collagen XVI belongs to the minor collagens
which are components of connective tissues like skin or carti-
lage. In skin it is located near basement membranes of blood
vessels and at the dermo-epithelial junction (DEJ) [5], with
an increased expression level in ﬁbrotic skin diseases [6]. Colla-
gen XVI forms homotrimers, with a length of 240 nm, visual-
ized as a rod-like structure with various kinks terminated by a
large N-terminal domain (NC 11) as determined by atomic
force microscopy and rotary shadowing [7]. Members of the
FACIT-family were ﬁrst described as being associated with
the surface of ﬁbrillar collagens, hypothesized to interconnect
heterotypic collagen ﬁbrils with each other to form large colla-
gen networks and to link these ﬁbrils to macromolecules of the
extraﬁbrillar matrix. In skin, collagen XVI is integrated into
particular ﬁbrillin-rich microﬁbrils lacking an amorphous elas-
tin core. In cartilage, collagen XVI is a component of small
heterotypic D-banded ﬁbrils, mainly occurring in the territo-
rial matrix of chondrocytes [8]. In contrast to members of ﬁbril
forming or basement membrane collagens, the FACIT-colla-
gen XVI has not yet been described in brain or tumor tissue.
Here, we study the expression of collagen XVI in glioblasto-
mas and investigate its impact on migration and adhesion of
glioblastoma cells.2. Materials and methods
2.1. Cell culture
Established human glioblastoma cell lines U87MG, U343MG,
U373MG and 86HG39, as well as primary glioblastoma cells
(TB288) were cultured as described [3]. For detection of collagen
XVI in cell culture supernatant, 1 · 106 cells were incubated in a
10 cm dish for 24 h in serum free medium.blished by Elsevier B.V. All rights reserved.
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Total RNA from native glioblastoma tissue (n = 10) obtained from
neurosurgical resections and normal brain tissue (n = 3) obtained by
autopsy from three adult subjects without neurological symptoms
and immediately frozen in liquid nitrogen, was isolated with TRIZOL
reagent (Invitrogen, Germany), while total RNA from cell lines was
isolated with RNeasy Mini Kit (Qiagen, Germany). Total RNA
(1 lg) was transcribed into cDNA with Omniscript RT (Qiagen). Con-
ventional RT-PCR with subsequent ethidium bromide gel electropho-
resis was performed using the following collagen XVI primers: 5 0-
ctggtgatcctgtacgagccagg-30 (forward) and 5 0-ccatcctgaaggttggacagggc-
3 0 (reverse). For quantitative RT-PCR TaqMan assays were performed
with TaqMan Universal PCR Master Mix and the collagen XVI Taq-
Man Gene Expression Assay HS_00156876m1 using the GeneAmp
5700 Sequence Detection System (reagents and detection system from
Applied Biosystems, USA). Primers and TaqMan-probe for GAPDH
control and calculation of relative expression intensity (DDCt-method)
were described previously [3]. Quantitative RT-PCR for b1 integrin
was performed with the primers: 5 0-atc cca gag gct cca aag at-3 0 (for-
ward) and 5 0-ccc ctg atc tta atc gca aa-3 0 (reverse) using the SYBR-
Green method, with GAPDH as internal loading control. Relative
changes in gene expression were evaluated by the DDCT-method. All
steps were performed according to manufacturers instructions.
2.3. Immunohistochemistry
For detection of collagen XVI in situ, 10 lm cryo sections from glio-
blastoma tissue were ﬁxed in methanol:acetone 1:1 at 20 C. After
blocking with 0.5% BSA in PBS the sections were incubated with a
polyclonal anti-collagen XVI antibody (raised in guinea pig; 1:100
dilution) [7] at 4 C over night. Pre-immune serum obtained from
the same animals served as negative control. Detection was performed
with a biotin-conjugated mouse anti-guinea pig IgG secondary anti-
body (Vector Laboratories, USA) using the avidin–biotin-complex
technique with peroxidase as enzyme and diaminobenzidine as sub-
strate (Vector Laboratories).
For double-immunoﬂuorescence deparaﬃnized and rehydrated sec-
tions were preincubated with protease XXIV (Sigma, Germany;
0.05% in PBS, 6 min, 37 C) and hyaluronidase (Sigma; 0.1% in so-
dium acetate buﬀer pH 6.0, 60 min, 37 C). After this treatment slides
were washed several times in PBS and unspeciﬁc binding sites were
blocked with PBS containing 1% bovine serum albumin (Biomol, Ger-
many), 5% normal goat serum (DAKO, Denmark) and 20% protease
inhibitor cocktail (Complete Mini, Roche, Germany) for 1 h at
37 C. The blocking was followed by overnight incubation at 4 C with
primary antibody. Primary antibodies were diluted in blocking buﬀer,
guinea pig anti-collagen XVI antibody 1:100, rabbit anti-collagen
(a1)IV antibody 1:500 (kind gift from J.A. Eble, Muenster) and rabbit
anti-GFAP 1:400 (DAKO). AlexaFluor555 (goat anti-guinea pig) and
AlexaFluor488 (goat anti-rabbit) conjugated antibodies (5 lg/ml,
Molecular Probes, USA) were added for 1 h at room temperature. Sec-
tions were counterstained with DAPI nucleic acid stain (300 nM in
PBS, Molecular Probes) and mounted with DAKO ﬂuorescent mount-
ing medium (DAKO).2.4. Western blotting
Cells and tissues were lysed with buﬀer containing 20 mM Tris, pH
7.6, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM phenylmethyl-
sulfonyl ﬂuoride, and 1% SDS. Cell culture supernatant was precipi-
tated with trichloric acetic acid and the sediment was resuspended in
lysis buﬀer. Equal amounts of proteins as determined using Lowry as-
say (BioRad, USA) were separated on a 7.5% polyacrylamide gel with
subsequent transfer onto nitrocellulose membrane (Schleicher and
Schu¨ll, Germany) using the wet blot technique. Detection was per-
formed with the polyclonal anti-collagen XVI guinea pig antibody
and a peroxidase conjugated mouse anti-guinea pig IgG secondary
antibody (Vector Laboratories) using the regular ECL plus detection
kit (Amersham, Germany). To verify equal protein loading on each
lane, blots were either stripped and reprobed for actin or checked by
means of uniform PonceauS staining.
2.5. Migration assay
To determine migration of glioma cells on surfaces coated with re-
combinant collagen XVI [7], we used the monolayer migration assay
as described elsewhere [3]. Surfaces were coated with 50 lg/ml recom-binant collagen XVI or BSA as control and cells were observed over a
period of 96 h. Increase of colony area was documented photographi-
cally and measurement was evaluated using the Sigma Scan Pro anal-
ysis software (SPSS Science, USA). Experiments were performed in
duplicates with 3–6 colonies investigated.
2.6. Adhesion assay
For investigating adhesion on recombinant collagen XVI 96-well
microtiter plates (Nunc, Germany) were coated by incubation with
100 ll per well of a recombinant collagen XVI solution (50 lg/ml) in
serum free DMEM for 1 h at 37 C. Wells were washed three times
with PBS and incubated with 100 ll of a 1 mg/ml BSA/PBS solution
for 30 min at room temperature. Adhesion depending on endogenous
collagen XVI after knockdown experiments was tested on uncoated
surfaces.
1 · 105 cells per well were incubated for 1 h under standard condi-
tions. Medium and non-adherent cells were aspirated and the wells
were washed three times with PBS. Cells were ﬁxed with 100 ll 3.7%
formaldehyde/PBS for 15 min and stained with 100 ll 0.5% crystal vio-
let in 3.7% formaldehyde/PBS overnight at 4 C. After aspirating the
dye solution, cells were washed four times with ddH2O, air-dried and
lysed in 100 ll 10% acetic acid on a shaker for 20 min. Absorption
was measured at 570 nm using an ELISA reader. Results are presented
as % absorption of controls using cells adherent on surfaces coated
only with BSA.
2.7. siRNA transfection
Knockdown of endogenous collagen XVI was performed using siR-
NA oligonucleotides 5 0-ugagcucauugagucaau-30 (siRNA1) and 5 0-
ggacucaaauuggaacaca-30 (siRNA2) with corresponding sequences as
double strand (Eurogenetec, Belgium) and non-interfering siRNA
(Qiagen) as control. Transfections were done in 6-well dishes with
3 · 105 cells each, using HiPerfect transfection reagent (Qiagen), fol-
lowing manufacturers instructions. Eﬃciency of knockdown was ana-
lyzed by qRT-PCR 48 h after transfection. At the same time the cells
were used for adhesion assays.
2.8. Statistical analysis
Diﬀerences in migration and adhesion were tested using two way
ANOVA for each cell line, time point or substrate respectively, using
LSD (least signiﬁcant diﬀerence) as post hoc-test if necessary.
P < 0.05 was considered as signiﬁcant.3. Results
3.1. Collagen XVI expression in glioma cells and tissues
Relative overexpression of collagen XVI in primary human
glioblastoma cells was initially detected in our oligonucleotide
microarray experiments [3]. To verify that these results ob-
tained with primary glioma cells reﬂected in situ conditions
and to exclude that collagen XVI expression represented a cell
culture artifact, we prepared RNA from human glioblastoma
specimens as well as from non-neoplastic cortex. In conven-
tional RT-PCRs the collagen XVI amplicon (345 bp) could
be exclusively detected in glioblastoma tissue, whereas in nor-
mal cortex tissue no transcription product was observed
(Fig. 1A). Quantitative RT-PCR applied to determine altered
expression, showed diﬀerences between tumor and normal tis-
sues. Relative quantiﬁcation of the data revealed 5–122-fold
overexpression of collagen XVI mRNA in tumor tissues
(Fig. 1B).
Using Western blotting collagen XVI protein was detected in
lysates of glioblastoma tissue but not in extracts from normal
cortex (Fig. 1C). In glioblastoma tissue, smaller truncated
forms were detected beside the full length protein, indicating
proteolytic digestion of collagen XVI in native tumor tissue.
The sizes of the processed fragments, 180 and 130 kDa, are
comparable to those seen with the recombinant forms [7] indi-
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Fig. 1. Detection of collagen XVI transcripts and protein in glioblastoma specimens and cell lines. Conventional RT-PCR was performed with RNA
from ﬁve glioblastoma specimens and with RNA from three non-neoplastic cortices. A 345 bp fragment speciﬁc for collagen XVI was only ampliﬁed
in glioblastomas, control RT-PCR was performed with GAPDH primers (A). Quantitative RT-PCR resulted in 5–122-fold induced expression of
collagen XVI mRNA in eight diﬀerent glioblastoma specimens as compared to normal cortex. The mean expression of three non-neoplastic cortices is
set to 1 and expression in glioma specimens is shown in x-fold relation to cortex (B). Full length collagen XVI with a molecular weight of 213 kDa
was detected in tissue lysates of three glioblastoma specimen but not in normal cortex. Smaller bands (180 and 130 kDa) detected by an anti-collagen
XVI antibody demonstrates the presence of processed fragments of collagen XVI, comparable to recombinant collagen XVI (rec.) (C). Collagen XVI
protein is expressed in considerable amounts in primary cells of a glioblastoma (TB288) and the glioblastoma cell lines U87MG and 86HG39,
whereas two other cell lines showed only very faint (U373MG) or no (U343MG) expression (D, upper panel). Secretion of collagen XVI was veriﬁed
in supernatants of primary TB288 cells and the established glioblastoma cell lines U87MG and 86HG39, but not in U343MG and U373MG (D,
lower panel).
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tumor cells. Full length collagen XVI (213 kDa) is found in
Western blots of cell lysates from some established glioma cell
lines or primary glioma cells. Western blotting of cell culture
supernatants revealed collagen XVI secretion by glioma cells
(Fig. 1D). Signiﬁcant amounts of collagen XVI were detected
in lysates from primary TB288 cells, as well as U87MG and
86HG39 cell lines. The other two cell lines revealed only a very
faint (U373MG) or no (U343MG) signal at all. In addition,
collagen XVI protein was detected in supernatants of two gli-
oma cell lines (U87MG and 86HG39) and the primary TB288cells, whereas two others (U373MG and U343MG) remained
negative. These results were corroborated by quantitative mea-
surements of mRNA levels from the respective cell lines (data
not shown).
Immunohistochemistry showed expression of collagen XVI
in glioblastoma specimens. We found strong staining of tumor
cells (Fig. 2A) or tumor vessels (Fig. 2C) in all investigated
glioblastomas. In tumors with cellular collagen XVI localiza-
tion nearly all tumor cells were histologically positive, while
normal cortex was virtually negative (Fig. 2E). Zones of the
dermal–epidermal junctions in normal skin served as positive
Fig. 2. Immunohistochemical localization of collagen XVI in glioblastoma tissues. Staining was found in tumor cells (A) and in tumor vessels (C,
arrows). Virtually no staining was found in normal cortex (E). Normal human skin, where zones of the dermal–epidermal junctions are known to be
positive for collagen XVI (G, arrows), served as positive control (see [15]). As negative controls tissues were incubated with pre-immune serum and
showed no staining (B, D, F, H). Sections were counterstained with haematoxylin.
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Fig. 3. Collagen XVI is expressed in GFAP positive cells and is underlying the basement membrane of tumor vessels. Double-immunoﬂuorescence
revealed collagen XVI expressing in GFAP positive cells, i.e. astrocytic tumor cells. Collagen XVI staining is shown (red in A), as well as staining with
GFAP (green in B) resulting in yellow overlay (C) of both ﬂuorescence staining and conﬁrming coexpression of both proteins. Staining of normal
cortex demonstrated only GFAP positive astrocytes (B 0) but no collagen XVI ﬂuorescence (A 0). Furthermore collagen XVI is located around tumor
vessels (red in D) together with collagen IV (green in E), overlay in (F). Nuclei are counterstained with DAPI.
V. Senner et al. / FEBS Letters 582 (2008) 3293–3300 3297control for collagen XVI staining (Fig. 2G). Double-immuno-
ﬂuorescence revealed staining of collagen XVI together with
GFAP in the same cells, indicating collagen XVI is produced
by the glioma cells (Fig. 3A–C). Collagen XVI was also found
in tumor vessels underlying the collagen IV layer (Fig. 3D–F).
3.2. Migration and adhesion
Migration and adhesion assays were performed using the cell
lines U87MG, 86HG39, U343MG and U373MG. Monolayer
migration on collagen XVI (50 lg/ml) coated surfaces revealed
no diﬀerences compared to BSA coated control surfaces in all
four tested cell lines (Fig. 4). In contrast to the migration re-sults, adhesion assays on surfaces coated with collagen XVI,
demonstrated increased adhesion (P < 0.05) for all glioma cell
lines at the highest coating concentration of 50 lg/ml com-
pared to BSA control or lower concentrations of collagen
XVI (Fig. 5A). There was also a signiﬁcant diﬀerence in the
strength of adhesion between the four cell lines at 50 l/ml col-
lagen XVI (U87MG > 86HG39 > U373MG > U343MG).
Next, we studied eﬀects of endogenous collagen XVI on adhe-
sion rates, using the cell line U87MG, which expresses detect-
able amounts of protein in the supernatant and showed the
strongest adhesion eﬀect on the recombinant protein. Collagen
XVI was knocked down with two diﬀerent siRNA constructs;
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Fig. 4. Migration of glioblastoma cell lines on collagen XVI coated surfaces. On surfaces coated with 50 lg/ml collagen XVI (dark columns)
migration rates remained unchanged compared to BSA (bright columns) coated surfaces. Results are the mean of two independent experiments with
3–6 replicates each.
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ments were done on uncoated surfaces. In transient transfec-
tions with siRNA oligonucleotides the amount of endogenous
collagen XVI mRNA decreased to 20% of controls transfected
with non-interfering siRNA. Cells with reduced collagen XVI
levels (using both siRNA oligonucleotides) exhibited signiﬁ-
cantly reduced adhesion rates (P < 0.05) compared with control
transfected cells and with non-transfected cells (Fig. 5B). How-
ever, analysis of b1 integrin transcripts of siRNA transfected
cells by quantitative RT-PCR, showed no changes in expres-
sion levels (data not shown). Thus, reduced adhesion is not a
consequence of decreased b1 integrin mRNA levels.4. Discussion
Collagen XVI represents the ﬁrst FACIT-collagen detected
in glioblastomas, as no other member of this protein family,
like collagens IX, XII, XIV and XIX, has been described as
being associated with this tumor so far. Immunohistochemi-
cally, collagen XVI is found in tumor vessels as well as in tu-
mor cells. Compared with normal human cortex, collagen
XVI expression is upregulated in glioma tissue and in a subset
of glioma cell lines, where it is secreted into the supernatant. In
cell culture assays with recombinant collagen XVI, there was
no detectable eﬀect on migration. However, glioma cell lines
adhered strongly to collagen XVI coated surfaces, while adhe-
sion was clearly reduced after blocking expression of endoge-
nous collagen XVI.
In adult mice collagen XVI expression is low in the CNS
which corroborates the absence of collagen XVI expression
in normal human brain [9]. Interestingly, collagen XVI is ex-
pressed in neurite growth cones, following axotomy [10], con-
necting its expression to cell movement. It is important to note
that collagen XVI expression in glioma cells is not a conse-
quence of the mesenchymal drift of tumor cells during cell cul-
ture [11], since tumor cells express collagen XVI in situ.
Furthermore, collagen XVI is an extracellular component of
tumor vessels underlying the vascular basement membrane
and it is well known that those membranes are preferred path-ways for glioma invasion. Nevertheless, expression of collagen
XVI is not a consistent feature of established glioma cell lines,
because we have found cell lines with profoundly diﬀering
expression levels. This reﬂects the heterogeneity of glioma cells
in situ, collagen XVI expression in a speciﬁc cell line presum-
ably being a feature of the initial cell clone forming a perma-
nent cell line. In ﬁbroblasts collagen XVI expression is
increased by transforming growth factor-b2 (TGF-b2) [12]
which is upregulated in gliomas [13], suggesting that overex-
pression of collagen XVI in gliomas may be a downstream ef-
fect of this growth factor.
Because members of the FACIT protein family serve as
molecular bridges between collagens and other components
of the extracellular matrix, interconnection by collagen XVI
may support the formation of migration pathways for glioma
cells. Although we have not found a migration promoting ef-
fect of pure collagen XVI in our monolayer migration assays,
collagen XVI may act as migration promoting substance only
in combination with other factors, e.g. in allocation of three
dimensional structures through interconnection to other struc-
tural proteins in brain speciﬁc ECM.
We have demonstrated that several glioma cell lines can uti-
lize collagen XVI as substrate for adhesion. The diﬀerent
strength of adhesion (U87MG > 86HG39 > U373MG-
> U343MG) is consistent with former investigations, demon-
strating diﬀerent abilities of diﬀerent cell lines to adhere to col-
lagen IV [14]. Collagen XVI interacts with integrins a1b1 and
a2b1, however, with a more avid binding to a1b1 [15]. Interac-
tion of gliomas with collagens is controlled by speciﬁc integrin
receptors provided by the cell. a1b1 and a2b1 integrins are
known to be expressed on glioma cell surfaces and are involved
in cell adhesion and migration [16,17].
Furthermore, knockdown of endogenous collagen XVI in
U87MG reduced the adhesion capacity of this cell line. It is
well known that glioma cells modulate their environment by
segregation of diﬀerent ECM components, with consequences
for adhesion and migration [18] which is also conceivable for
collagen XVI. For this FACIT-collagen the deposition into
the pericellular ECM of ﬁbroblasts and smooth muscle cells
has already been reported [19].
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Fig. 5. Adhesion of glioblastoma cell lines on collagen XVI coated
surfaces and after siRNA mediated inhibition of endogenous collagen
XVI on uncoated surfaces. There was signiﬁcantly higher adhesion of
all four glioblastoma cell lines on surfaces coated with 50 lg/ml
collagen XVI compared to lower collagen XVI concentrations and
BSA coated controls. Results are the mean of two (U87MG,
U343MG, U373MG) or three (86HG39) independent experiments
with 6-fold replicates each. (* = P < 0.05) (A). SiRNA mediated
knockdown of endogenous collagen XVI in U87MG cells was
performed with transient transfection using two diﬀerent siRNA
oligonucleotides (si1 and si2). Both transfections resulted in collagen
XVI inhibition of more than 80% compared to the non-interfering
control transfections (ct). Transfection with two collagen XVI speciﬁc
siRNA oligonucleotides resulted in decreased adhesion on uncoated
surfaces, whereas adhesion was not signiﬁcantly diﬀerent for control
transfected cells (ct) and non-transfected cells (nt). Results are the
mean of three independent experiments with 6-fold replicates each.
(* = P < 0.05, ns = not signiﬁcant) (B).
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ments of lower molecular weight in glioblastoma tissue and
TB288 cells, most likely being identical with the processed
180 kDa form lacking the N-terminal NC11 domain and the
130 kDa form which misses C-terminal regions [7]. This obser-
vation leads to the intriguing speculation that collagen XVI
has functions other than mere matrix receptor interactions,
perhaps including regulatory functions of the proteolytic 180
and 130 kDa fragments. Proteolytic fragments from collagen
IV (tumstatin) and XVIII (endostatin) transfer anti-angiogenic
eﬀects, subsequently inﬂuencing cell growth and migration
[20]. The C-terminal NC 1 domain of these collagens contains
recognition sites for several matrix metalloproteinases, which
are known to be hyperactive in gliomas [2]. It is intriguing to
speculate that corresponding domains of collagen XVI fulﬁll
regulatory functions in cell migration and adhesion. Notably,
endorepellin, which represents the C-terminal domain of theheparansulfate proteoglycan perlecan [20], inhibits endothelial
cell migration and binds to a2b1 integrin, which has a binding
site in the C-terminus of collagen XVI [15]. The cell line
U87MG is therefore an interesting model for further investiga-
tions concerning collagen XVI functions in gliomas.Acknowledgements: We thank Birgit Heuer and Andrea Wagner for
excellent technical assistance. This study was supported by Wilhelm-
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